methazolamide has been researched along with Diabetic Cardiomyopathies in 1 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X | 1 |
| Li, Y | 1 |
| Yuan, X | 1 |
| Yuan, W | 1 |
| Li, C | 1 |
| Zeng, Y | 1 |
| Lian, Y | 1 |
| Qiu, X | 1 |
| Qin, Y | 1 |
| Zhang, G | 1 |
| Liu, X | 1 |
| Luo, C | 1 |
| Luo, JD | 1 |
| Hou, N | 1 |
1 other study available for methazolamide and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Methazolamide Attenuates the Development of Diabetic Cardiomyopathy by Promoting β-Catenin Degradation in Type 1 Diabetic Mice.
Topics: Animals; Axin Protein; beta Catenin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dia | 2022 |